Literature DB >> 3101140

The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy.

W Duncan, P M Quilty.   

Abstract

The results are reported of a large series of patients with transitional cell cancer of the bladder, treated in Edinburgh between 1971 and 1982. Analysis of pre-treatment characteristics for patients with transitional cell bladder cancer showed that tumour category was significantly associated with grade and tumour size. Complete local tumour regression at follow-up cystoscopy was achieved in 45.9% of patients who completed radical megavoltage X-ray therapy. Patients with grade 2 or 3 cancer, a solid cancer or a tumour of less than 8 cm in size had significantly improved complete regression rates. Lasting local tumour control after initial complete regression was better in patients with grade 3 cancer. Complete regression was associated with improved survival for all but patients with T1 cancer. The poorest (uncorrected) survival rates were seen in patients over 79 years of age, those with T4 cancer, an ulcerated cancer, a grade 3 cancer or a tumour of more than 7 cm in size. Metastases were more often seen in patients with grade 3 or T3/T4 cancer. Severe late radiation-related complications were seen in 14.8% of patients.

Entities:  

Mesh:

Year:  1986        PMID: 3101140     DOI: 10.1016/s0167-8140(86)80059-7

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  20 in total

Review 1.  Radiation dose-volume effects of the urinary bladder.

Authors:  Akila N Viswanathan; Ellen D Yorke; Lawrence B Marks; Patricia J Eifel; William U Shipley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

Review 2.  Bladder cancer.

Authors:  H Y Leung; T R Griffiths; D E Neal
Journal:  Postgrad Med J       Date:  1996-12       Impact factor: 2.401

Review 3.  Epidermal growth factor receptor and bladder cancer.

Authors:  A J Colquhoun; J K Mellon
Journal:  Postgrad Med J       Date:  2002-10       Impact factor: 2.401

Review 4.  New approaches in the use of radiation therapy in the treatment of infiltrative transitional-cell cancer of the bladder.

Authors:  P Warde; M K Gospodarowicz
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 5.  Therapeutic interventions targeting organ preservation in muscle-invasive bladder cancer: a review.

Authors:  Georgios Koukourakis; Vassilios Kouloulias; Georgios Zacharias; Anastasia Sotiropoulou-Lontou; Michael Koukourakis
Journal:  Clin Transl Oncol       Date:  2011-05       Impact factor: 3.405

Review 6.  Contemporary management of muscle-invasive bladder cancer.

Authors:  Faysal A Yafi; Jordan R Steinberg; Wassim Kassouf
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

Review 7.  Multimodal management of muscle-invasive bladder cancer.

Authors:  Jong Chul Park; Deborah E Citrin; Piyush K Agarwal; Andrea B Apolo
Journal:  Curr Probl Cancer       Date:  2014-06-23       Impact factor: 3.187

Review 8.  Combined chemotherapy and external beam radiotherapy for transitional cell carcinoma of the bladder.

Authors:  Ronald D Ennis
Journal:  Curr Oncol Rep       Date:  2004-05       Impact factor: 5.075

Review 9.  Landmarks in the treatment of muscle-invasive bladder cancer.

Authors:  Niyati Lobo; Chloe Mount; Kawa Omar; Rajesh Nair; Ramesh Thurairaja; Muhammad Shamim Khan
Journal:  Nat Rev Urol       Date:  2017-07-04       Impact factor: 14.432

10.  Conservative treatment of invasive bladder cancer.

Authors:  N J Rene; F B Cury; L Souhami
Journal:  Curr Oncol       Date:  2009-08       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.